Doxorubicin Terminated Phase 2 Trials for Diffuse Large B-Cell Lymphoma (DLBCL) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02531308Metformin in Combination With Standard Induction Therapy for Large B-cell Lymphoma (DLBCL)